EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice

Yan Su, Yunjon Han, Hack Sun Choi, Gil-Yong Lee, Hee Won Cho, Heonsik Choi, Yong-Suk Jang, Jong Hyun Choi, Jeong-Woo Seo

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yan Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-Si 56212, South Korea; Department…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Gastrointestinal Microbiome, Docosahexaenoic Acids, Anti-Inflammatory Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea, Korea Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin condition that primarily results from immune dysregulation. We determined the potential therapeutic benefits of lipid mediators (LM, 17S-monohydroxy DHA, resolvin D5, and protectin DX in a ratio of 3:47:50) produced by soybean lipoxygenase from DHA. The underlying molecular mechanisms involved in TNF-α/IFN-γ-stimulated HaCaT cells as well as its effect in an AD mouse model induced by DNCB in BALB/c mice were examined. The results indicated that LM effectively attenuates the production of inflammatory cytokines (IL-6 and IL-1β) and chemokines (IL-8 and MCP-1) by inhibiting the NF-κB signaling pathway in TNF-α/IFN-γ-stimulated HaCaT cells. The oral administration of LM at 5 or 10 μg/kg/day significantly reduced skin lesions, epidermal thickness, and mast cell infiltration in AD mice. Furthermore, LM reduced the production of IgE and inflammatory cytokines (TNF-α, IL-6, and IL-1β) in the serum, modulated gut microbiota diversity, and restored the microbial composition. Overall, our findings suggest that LM represents a potential therapeutic agent for improving AD symptoms through its ability to suppress inflammatory cytokines and alter the composition of gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicGastrointestinal MicrobiomeDocosahexaenoic AcidsAnti-Inflammatory AgentsAnimalsMice, Inbred BALB CCytokinesHumansMiceDinitrochlorobenzeneDisease Models, AnimalSkinNF-kappa BHaCaT CellsImmunoglobulin EFemale

Stichwörter der Autor:innen

Atopic dermatitisGut microfloraInflammationLipid mediators

Substanzen

CytokinesDocosahexaenoic AcidsDinitrochlorobenzeneNF-kappa BImmunoglobulin EAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-Si 56212, South Korea; Department of Bioactive Material Sciences, Jeonbuk National University, Jeonju 5…
  • Microbial Biotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup-Si 56212, South Korea. Electronic address: gugin@kribb.re.kr.
  • Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, Jeju 63243, South Korea. Electronic address: choix074@jejunu.ac.kr.
  • Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, South Korea. Electronic address: enlicoo@kolon.com.
  • Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, South Korea. Electronic address: heewoncho@kolon.com.
  • Healthcare Technology Institute, Kolon Advanced Research Center, 110 Magokdong-ro, Seoul 07793, South Korea. Electronic address: heonsik@kolon.com.

Förderung

  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Foundation of Korea
  • Korea Ministry of Science and ICT
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Su, Y., Han, Y., Choi, H. S., Lee, G. Y., Cho, H. W., Choi, H., Jang, Y. S., Choi, J. H., & Seo, J. W. (2023). Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110900

Vancouver

Su Y, Han Y, Choi HS, Lee GY, Cho HW, Choi H, et al. Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110900

BibTeX
@article{Su2023,
  author = {Su, Yan and Han, Yunjon and Choi, Hack Sun and Lee, Gil-Yong and Cho, Hee Won and Choi, Heonsik and Jang, Yong-Suk and Choi, Jong Hyun and Seo, Jeong-Woo},
  title = {Lipid mediators derived from DHA alleviate DNCB-induced atopic dermatitis and improve the gut microbiome in BALB/c mice},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110900}
}
Kostenlos starten →